Skip to content

Clinical trials

Phase 3 Atrial Fibrillation trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 3 Country / region: Sweden Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20034
20041
20053
20062
20073
20083
20101
20131
20142
20161
20181
20222
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated5
Recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi8
Boehringer Ingelheim3
Advanz Pharma2
Astellas Pharma Inc2
Bristol-Myers Squibb2
Daiichi Sankyo2
Region Stockholm2
Region Örebro County2
Anthos Therapeutics, Inc.1
Atrial Fibrillation Network1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation29
Stroke6
Atrial Flutter3
Arrhythmias, Cardiac2
Cardiovascular Diseases2
Embolism2
Heart Diseases2
Acute Coronary Syndrome1
Acute Kidney Injury1
Atherosclerosis1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.